<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39335455</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Uncovering the Contrasts and Connections in PASC: Viral Load and Cytokine Signatures in Acute COVID-19 versus Post-Acute Sequelae of SARS-CoV-2 (PASC).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1941</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12091941</ELocationID><Abstract><AbstractText>The recent global COVID-19 pandemic has had a profound and enduring impact, resulting in substantial loss of life. The scientific community has responded unprecedentedly by investigating various aspects of the crisis, particularly focusing on the acute phase of COVID-19. The roles of the viral load, cytokines, and chemokines during the acute phase and in the context of patients who experienced enduring symptoms upon infection, so called Post-Acute Sequelae of COVID-19 or PASC, have been studied extensively. Here, in this review, we offer a virologist's perspective on PASC, highlighting the dynamics of SARS-CoV-2 viral loads, cytokines, and chemokines in different organs of patients across the full clinical spectrum of acute-phase disease. We underline that the probability of severe or critical disease progression correlates with increased viral load levels detected in the upper respiratory tract (URT), lower respiratory tract (LRT), and plasma. Acute-phase viremia is a clear, although not unambiguous, predictor of PASC development. Moreover, both the quantity and diversity of functions of cytokines and chemokines increase with acute-phase disease severity. Specific cytokines remain or become elevated in the PASC phase, although the driving factor of ongoing inflammation found in patients with PASC remains to be investigated. The key findings highlighted in this review contribute to a further understanding of PASC and their differences and overlap with acute disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Compeer</LastName><ForeName>Brandon</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Artemis Bioservices B.V., 2629 JD Delft, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, University Medical Center Amsterdam (UMC, Amsterdam), 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neijzen</LastName><ForeName>Tobias R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Spaarne Gasthuis, 2035 RC Haarlem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Lelyveld</LastName><ForeName>Steven F L</ForeName><Initials>SFL</Initials><Identifier Source="ORCID">0000-0001-9153-8196</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Spaarne Gasthuis, 2035 RC Haarlem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martina</LastName><ForeName>Byron E E</ForeName><Initials>BEE</Initials><AffiliationInfo><Affiliation>Artemis Bioservices B.V., 2629 JD Delft, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Colin A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, University Medical Center Amsterdam (UMC, Amsterdam), 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goeijenbier</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, University Medical Center Amsterdam (UMC, Amsterdam), 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Erasmus MC University Medical Centre, 3015 GD Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">lower respiratory tract</Keyword><Keyword MajorTopicYN="N">plasma</Keyword><Keyword MajorTopicYN="N">upper respiratory tract</Keyword><Keyword MajorTopicYN="N">viral load</Keyword></KeywordList><CoiStatement>Author Brandon Compeer and Byron E. E. Martina were employed by the company &#x201c;Artemis Bioservices&#x201d;. The remaining authors declare that the re-search was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39335455</ArticleId><ArticleId IdType="pmc">PMC11428903</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12091941</ArticleId><ArticleId IdType="pii">biomedicines12091941</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  WHO COVID-19 Dashboard.  [(accessed on 5 March 2024)].  Available online:  https://data.who.int/dashboards/covid19/deaths?n=c.</Citation></Reference><Reference><Citation>Bulut C., Kato Y. Epidemiology of COVID-19. Turk. J. Med. Sci. 2020;50:563&#x2013;570. doi: 10.3906/sag-2004-172.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-2004-172</ArticleId><ArticleId IdType="pmc">PMC7195982</ArticleId><ArticleId IdType="pubmed">32299206</ArticleId></ArticleIdList></Reference><Reference><Citation>FAIR Health . Patients Diagnosed with Post-COVID Conditions an Analysis of Private Healthcare Claims Using the Official ICD-10 Diagnostic Code. FAIR Health; New York, NY, USA: 2022.</Citation></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew F., Efstathiou C., Fontanella S., Richardson M., Saunders R., Swieboda D., Sidhu J.K., Ascough S., Moore S.C., Mohamed N., et al. Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nat. Immunol. 2024;25:607&#x2013;621. doi: 10.1038/s41590-024-01778-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-024-01778-0</ArticleId><ArticleId IdType="pmc">PMC11003868</ArticleId><ArticleId IdType="pubmed">38589621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozonoff A., Jayavelu N.D., Liu S., Melamed E., Milliren C.E., Qi J., Geng L.N., McComsey G.A., Cairns C.B., Baden L.R., et al. Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: Results from the IMPACC study. Nat. Commun. 2024;15 doi: 10.1038/s41467-023-44090-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-44090-5</ArticleId><ArticleId IdType="pmc">PMC10764789</ArticleId><ArticleId IdType="pubmed">38172101</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujadas E., Chaudhry F., McBride R., Richter F., Zhao S., Wajnberg A., Nadkarni G., Glicksberg B.S., Houldsworth J., Cordon-Cardo C. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir. Med. 2020;8:e70. doi: 10.1016/S2213-2600(20)30354-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30354-4</ArticleId><ArticleId IdType="pmc">PMC7836878</ArticleId><ArticleId IdType="pubmed">32771081</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Yan L.-M., Wan L., Xiang T.-X., Le A., Liu J.-M., Peiris M., Poon L.L.M., Zhang W. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect. Dis. 2020;20:656&#x2013;657. doi: 10.1016/S1473-3099(20)30232-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30232-2</ArticleId><ArticleId IdType="pmc">PMC7158902</ArticleId><ArticleId IdType="pubmed">32199493</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjendra Y., Al Mana A.F., Espejo A.P., Akgun Y., Millan N.C., Gomez-Fernandez C., Cray C. Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers. Arch. Pathol. Lab. Med. 2020;144:1465&#x2013;1474. doi: 10.5858/arpa.2020-0471-SA.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2020-0471-SA</ArticleId><ArticleId IdType="pubmed">32818235</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer R.R., Rock M.A., Vasilevsky N., Carmody L., Rando H., Anzalone A.J., Basson M.D., Bennett T.D., Bergquist T., Boudreau E.A., et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine. 2021;74 doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Thorpe L.E., Simon N.M., de Havenon A., Yaghi S., Sabadia S.B., Yang D., Lewis A., Melmed K., Balcer L.J., et al. Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: A prospective, observational study. PLoS ONE. 2022;17:e0275274. doi: 10.1371/journal.pone.0275274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0275274</ArticleId><ArticleId IdType="pmc">PMC9521913</ArticleId><ArticleId IdType="pubmed">36174032</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Sivan M., Perlowski A., Nikolich J. Long COVID: A clinical update. Lancet. 2024;404:707&#x2013;724. doi: 10.1016/S0140-6736(24)01136-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(24)01136-X</ArticleId><ArticleId IdType="pubmed">39096925</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumura T., Okamoto T., Tosaka M., Yamana T., Shimada S., Iijima Y., Sakakibara R., Shibata S., Honda T., Shirai T., et al. Association of SARS-CoV-2 RNA Copy Number with the COVID-19 Mortality Rate and Its Effect on the Predictive Performance of Mortality in Severe Cases. Jpn. J. Infect. Dis. 2022;75:504&#x2013;510. doi: 10.7883/yoken.JJID.2022.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken.JJID.2022.080</ArticleId><ArticleId IdType="pubmed">35650037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasanoglu I., Korukluoglu G., Asilturk D., Cosgun Y., Kalem A.K., Altas A.B., Kayaaslan B., Eser F., Kuzucu E.A., Guner R. Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg. Infection. 2021;49:117&#x2013;126. doi: 10.1007/s15010-020-01548-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01548-8</ArticleId><ArticleId IdType="pmc">PMC7685188</ArticleId><ArticleId IdType="pubmed">33231841</ArticleId></ArticleIdList></Reference><Reference><Citation>Puchinger K., Castelletti N., Rubio-Acero R., Geldmacher C., Eser T.M., De&#xe1;k F., Paunovic I., Bakuli A., Saathoff E., von Meyer A., et al. The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2&#x2014;Results from a prospective cohort of outpatient COVID-19 cases. Virology. 2022;569:37&#x2013;43. doi: 10.1016/j.virol.2022.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2022.02.002</ArticleId><ArticleId IdType="pmc">PMC8855229</ArticleId><ArticleId IdType="pubmed">35245784</ArticleId></ArticleIdList></Reference><Reference><Citation>Magleby R., Westblade L.F., Trzebucki A., Simon M.S., Rajan M., Park J., Goyal P., Safford M.M., Satlin M.J. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality among Hospitalized Patients with Coronavirus Disease 2019. Clin. Infect. Dis. 2021;73:E4197&#x2013;E4205. doi: 10.1093/cid/ciaa851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa851</ArticleId><ArticleId IdType="pmc">PMC7337625</ArticleId><ArticleId IdType="pubmed">32603425</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyapati A., Wipperman M.F., Ehmann P.J., Hamon S., Lederer D.J., Waldron A., Flanagan J.J., Karayusuf E., Bhore R., Nivens M.C., et al. Baseline Severe Acute Respiratory Syndrome Viral Load Is Associated with Coronavirus Disease 2019 Severity and Clinical Outcomes: Post Hoc Analyses of a Phase 2/3 Trial. J. Infect. Dis. 2021;224:1830&#x2013;1838. doi: 10.1093/infdis/jiab445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab445</ArticleId><ArticleId IdType="pmc">PMC8522400</ArticleId><ArticleId IdType="pubmed">34496013</ArticleId></ArticleIdList></Reference><Reference><Citation>Souverein D., van Stralen K., van Lelyveld S., van Gemeren C., Haverkort M., Snijders D., Soetekouw R., Kapteijns E., de Jong E., Hermanides G., et al. Initial Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load Is Associated with Disease Severity: A Retrospective Cohort Study. Open Forum Infect. Dis. 2022;9:ofac223. doi: 10.1093/ofid/ofac223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac223</ArticleId><ArticleId IdType="pmc">PMC9272435</ArticleId><ArticleId IdType="pubmed">35821732</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Chen D., Hou J., Li H., Cao D., Guo M., Ling Y., Gao M., Zhou Y., Wan Y., et al. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis. Cytokine. 2021;138:155365. doi: 10.1016/j.cyto.2020.155365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2020.155365</ArticleId><ArticleId IdType="pmc">PMC7651249</ArticleId><ArticleId IdType="pubmed">33246770</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X. COVID-19: Immunopathology and its implications for therapy. Nat. Rev. Immunol. 2020;20:269&#x2013;270. doi: 10.1038/s41577-020-0308-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0308-3</ArticleId><ArticleId IdType="pmc">PMC7143200</ArticleId><ArticleId IdType="pubmed">32273594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ynga-Durand M., Maa&#xdf; H., Milo&#x161;evi&#x107; M., Krstanovi&#x107; F., Mate&#x161;i&#x107; M.P., Jonji&#x107; S., Proti&#x107; A., Brizi&#x107; I., &#x160;usti&#x107; A., &#x10c;i&#x10d;in-&#x160;ain L. SARS-CoV-2 Viral Load in the Pulmonary Compartment of Critically Ill COVID-19 Patients Correlates with Viral Serum Load and Fatal Outcomes. Viruses. 2022;14:1292. doi: 10.3390/v14061292.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14061292</ArticleId><ArticleId IdType="pmc">PMC9228931</ArticleId><ArticleId IdType="pubmed">35746764</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Martin J.F., Garc&#xed;a-Mateo N., Motos A., Resino S., Tamayo L., Murua P.R., Bustamante-Munguira E., Curto E.G., &#xda;beda-Iglesias A., Torre M.d.C.d.l., et al. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: A multicentre, prospective, cohort study. Lancet Microbe. 2023;4:e431&#x2013;e441. doi: 10.1016/S2666-5247(23)00041-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00041-1</ArticleId><ArticleId IdType="pmc">PMC10129133</ArticleId><ArticleId IdType="pubmed">37116517</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli A., Righini E., Micheli V., Pinoli P., Bernasconi A., Rizzo A., Oreni L., Ridolfo A.L., Antinori S., Ceri S., et al. SARS-CoV-2 viremia and COVID-19 mortality: A prospective observational study. PLoS ONE. 2023;18:e0281052.18. doi: 10.1371/journal.pone.0281052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0281052</ArticleId><ArticleId IdType="pmc">PMC10146509</ArticleId><ArticleId IdType="pubmed">37115764</ArticleId></ArticleIdList></Reference><Reference><Citation>Karron R.A., Hetrich M.K., Bin Na Y., Knoll M.D., Schappell E., Meece J., Hanson E., Tong S., Lee J.S., Veguilla V., et al. Assessment of Clinical and Virological Characteristics of SARS-CoV-2 Infection Among Children Aged 0 to 4 Years and Their Household Members. JAMA Netw. Open. 2022;5:e2227348. doi: 10.1001/jamanetworkopen.2022.27348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.27348</ArticleId><ArticleId IdType="pmc">PMC9434363</ArticleId><ArticleId IdType="pubmed">36044218</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J.L., Bain W., Naqvi A., Staines B., Castanha P.M.S., Yang H., Boltz V.F., Barratt-Boyes S., Marques E.T.A., Mitchell S.L., et al. Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated with Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes. Clin. Infect. Dis. 2022;74:1525&#x2013;1533. doi: 10.1093/cid/ciab686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab686</ArticleId><ArticleId IdType="pmc">PMC9070832</ArticleId><ArticleId IdType="pubmed">34374761</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health  Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.  [(accessed on 21 March 2024)]; Available online:  https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Sun S., Shi Y., Wang H., Zhao R., Sheng J. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression. Crit. Care. 2020;24:1&#x2013;4. doi: 10.1186/s13054-020-02893-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02893-8</ArticleId><ArticleId IdType="pmc">PMC7179376</ArticleId><ArticleId IdType="pubmed">32326952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn J.H., Kim J.M., Hong S.P., Choi S.Y., Yang M.J., Ju Y.S., Kim Y.T., Kim H.M., Rahman T., Chung M.K., et al. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J. Clin. Investig. 2021;131 doi: 10.1172/JCI148517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI148517</ArticleId><ArticleId IdType="pmc">PMC8245175</ArticleId><ArticleId IdType="pubmed">34003804</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#x2019;Kovski P., Kratzel A., Steiner S., Stalder H., Thiel V. Coronavirus biology and replication: Implications for SARS-CoV-2. Nat. Rev. Microbiol. 2021;19:155&#x2013;170. doi: 10.1038/s41579-020-00468-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00468-6</ArticleId><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D., Kearney M.F., O&#x2019;Regan A., O&#x2019;Donnell J.S., Quartuccio L., Watad A., Bridgewood C. Therapeutic implications of ongoing alveolar viral replication in COVID-19. Lancet Rheumatol. 2022;4:e135&#x2013;e144. doi: 10.1016/S2665-9913(21)00322-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00322-2</ArticleId><ArticleId IdType="pmc">PMC8635460</ArticleId><ArticleId IdType="pubmed">34873587</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajnzylber J., Regan J., Coxen K., Corry H., Wong C., Rosenthal A., Worrall D., Giguel F., Piechocka-Trocha A., Atyeo C., et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat. Commun. 2020;11:5493. doi: 10.1038/s41467-020-19057-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19057-5</ArticleId><ArticleId IdType="pmc">PMC7603483</ArticleId><ArticleId IdType="pubmed">33127906</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui K.P.Y., Ho J.C.W., Cheung M.-C., Ng K.-C., Ching R.H.H., Lai K.-L., Kam T.T., Gu H., Sit K.-Y., Hsin M.K.Y., et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022;603:715&#x2013;720. doi: 10.1038/s41586-022-04479-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04479-6</ArticleId><ArticleId IdType="pubmed">35104836</ArticleId></ArticleIdList></Reference><Reference><Citation>Puhach O., Adea K., Hulo N., Sattonnet P., Genecand C., Iten A., Jacqu&#xe9;rioz F., Kaiser L., Vetter P., Eckerle I., et al. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2. Nat. Med. 2022;28:1491&#x2013;1500. doi: 10.1038/s41591-022-01816-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01816-0</ArticleId><ArticleId IdType="pubmed">35395151</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Raddad L.J., Chemaitelly H., Bertollini R. Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections. N. Engl. J. Med. 2021;385:2487&#x2013;2489. doi: 10.1056/NEJMc2108120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2108120</ArticleId><ArticleId IdType="pmc">PMC8631440</ArticleId><ArticleId IdType="pubmed">34818474</ArticleId></ArticleIdList></Reference><Reference><Citation>Omololu A., Ojelade B., Ajayi O., Adesomi T., Alade O., Adebisi S., Nwadike V. &#x201c;Long COVID&#x201d;: A case report of persistent symptoms in a patient with prolonged SARS-CoV-2 shedding for over 110 days. SAGE Open Med. Case Rep. 2021;9:2050313X211015494. doi: 10.1177/2050313X211015494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050313X211015494</ArticleId><ArticleId IdType="pmc">PMC8132077</ArticleId><ArticleId IdType="pubmed">34035919</ArticleId></ArticleIdList></Reference><Reference><Citation>Viszlayov&#xe1; D., Sojka M., Dobrodenkov&#xe1; S., Szab&#xf3; S., Bilec O., Turzov&#xe1; M., &#x10e;urina J., Baloghov&#xe1; B., Borb&#xe9;ly Z., Kr&#x161;&#xe1;k M. SARS-CoV-2 RNA in the Cerebrospinal Fluid of a Patient with Long COVID. Ther. Adv. Infect. Dis. 2021;8:204993612110485. doi: 10.1177/20499361211048572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211048572</ArticleId><ArticleId IdType="pmc">PMC8511908</ArticleId><ArticleId IdType="pubmed">34659752</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadtm&#xfc;ller M., Laubner A., Rost F., Winkler S., Patrasov&#xe1; E., &#x160;im&#x16f;nkov&#xe1; L., Reinhardt S., Beil J., Dalpke A.H., Yi B. Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants. Virus Evol. 2022;8:veac010. doi: 10.1093/ve/veac010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac010</ArticleId><ArticleId IdType="pmc">PMC9048873</ArticleId><ArticleId IdType="pubmed">35494175</ArticleId></ArticleIdList></Reference><Reference><Citation>Menezes S.M., Jamoulle M., Carletto M.P., Jamoulle M., Carletto M.P., Van Holm B., Moens L., Meyts I., Maes P., Van Weyenbergh J. Blood transcriptomics reveal persistent SARS-CoV-2 RNA and candidate biomarkers in Long COVID patients. medrXiv. 2024 doi: 10.1101/2024.01.14.24301293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.01.14.24301293</ArticleId><ArticleId IdType="pubmed">38677304</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V., Mahajan A., Krishnamachary B., Spikes L., Chalise P., Dhillon N.K. Persistent Presence of Spike protein and Viral RNA in the Circulation of Individuals with Post-Acute Sequelae of COVID-19. medRxiv. 2022 doi: 10.1101/2022.08.07.22278520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.07.22278520</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Rombauts A., Infante C., Lagos M.d.A.M.d., Alba J., Valiente A., Donado-Mazarr&#xf3;n C., Carretero-Ledesma M., Rodr&#xed;guez-&#xc1;lvarez R., Omatos S., Palacios-Baena Z.R., et al. Impact of SARS-CoV-2 RNAemia and other risk factors on long-COVID: A prospective observational multicentre cohort study. J. Infect. 2023;86:154&#x2013;225. doi: 10.1016/j.jinf.2022.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.11.009</ArticleId><ArticleId IdType="pmc">PMC9671615</ArticleId><ArticleId IdType="pubmed">36403699</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram-Mohan N., Kim D., Rogers A.J., Blish C.A., Nadeau K.C., Blomkalns A.L., Yang S. Association Between SARS-CoV-2 RNAemia and Postacute Sequelae of COVID-19. Open Forum Infect. Dis. 2022;9:ofab646. doi: 10.1093/ofid/ofab646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab646</ArticleId><ArticleId IdType="pmc">PMC8802799</ArticleId><ArticleId IdType="pubmed">35111870</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez D.A.G., Fonseca-Ag&#xfc;ero A., Toledo-Ibarra G.A., Gomez-Valdivia J.d.J., D&#xed;az-Resendiz K.J.G., Benitez-Trinidad A.B., Razura-Carmona F.F., Navidad-Murrieta M.S., Covantes-Rosales C.E., Giron-P&#xe9;rez M.I. Post-COVID-19 Syndrome in Outpatients and Its Association with Viral Load. Int. J. Environ. Res. Public. Health. 2022;19:15145. doi: 10.3390/ijerph192215145.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192215145</ArticleId><ArticleId IdType="pmc">PMC9690223</ArticleId><ArticleId IdType="pubmed">36429864</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of Post COVID-19 Condition Symptoms: A Systematic Review and Meta-Analysis of Cohort Study Data, Stratified by Recruitment Setting Key Facts. European Centre for Disease Prevention and Control; Solna, Sweeden: 2022. European Centre for Disease Prevention and Control.</Citation></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S.B., Force R.M.P.T., Hospital M.G., Mit, Harvard, Angeles C.H.L., States U. Viral persistence, reactivation, and mechanisms of long COVID. eLife. 2023;12:e86015. doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Richards A., Inmaculada Barrasa M., Hughes S.H., Young R.A., Jaenisch R. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc. Nat. Acad. Sci. USA. 2021;118:e2105968118. doi: 10.1073/pnas.2105968118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105968118</ArticleId><ArticleId IdType="pmc">PMC8166107</ArticleId><ArticleId IdType="pubmed">33958444</ArticleId></ArticleIdList></Reference><Reference><Citation>Randall R.E., Griffin D.E. Within host RNA virus persistence: Mechanisms and consequences. Curr. Opin. Virol. 2017;23:35&#x2013;42. doi: 10.1016/j.coviro.2017.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2017.03.001</ArticleId><ArticleId IdType="pmc">PMC5474179</ArticleId><ArticleId IdType="pubmed">28319790</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y.-D., Ding M., Dong X., Zhang J.-J., Azkur A.K., Azkur D., Gan H., Sun Y.-L., Fu W., Li W., et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021;76:428&#x2013;455. doi: 10.1111/all.14657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwabara T., Ishikawa F., Kondo M., Kakiuchi T. The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases. Mediat. Inflamm. 2017;2017:3908061. doi: 10.1155/2017/3908061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/3908061</ArticleId><ArticleId IdType="pmc">PMC5337858</ArticleId><ArticleId IdType="pubmed">28316374</ArticleId></ArticleIdList></Reference><Reference><Citation>Velazquez-Salinas L., Verdugo-Rodriguez A., Rodriguez L.L., Borca M.V. The Role of Interleukin 6 During Viral Infections. Front. Microbiol. 2019;10:01057. doi: 10.3389/fmicb.2019.01057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01057</ArticleId><ArticleId IdType="pmc">PMC6524401</ArticleId><ArticleId IdType="pubmed">31134045</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlini V., Noonan D.M., Abdalalem E., Goletti D., Sansone C., Calabrone L., Albini A. The multifaceted nature of IL-10: Regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front. Immunol. 2023;14:1161067. doi: 10.3389/fimmu.2023.1161067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1161067</ArticleId><ArticleId IdType="pmc">PMC10287165</ArticleId><ArticleId IdType="pubmed">37359549</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawawi Z.M., Kalyanasundram J., Zain R.M., Thayan R., Basri D.F., Yap W.B. Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-&#x3b1;) in COVID-19: Prognosis, Therapeutic and Management. Int. J. Mol. Sci. 2023;24:6142. doi: 10.3390/ijms24076142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24076142</ArticleId><ArticleId IdType="pmc">PMC10094668</ArticleId><ArticleId IdType="pubmed">37047115</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong-Quy S., Vo-Pham-Minh T., Tran-Xuan Q., Huynh-Anh T., Vo-Van T., Vu-Tran-Thien Q., Nguyen-Nhu V. Post-COVID-19 Pulmonary Fibrosis: Facts&#x2014;Challenges and Futures: A Narrative Review. Pulm. Ther. 2023;20:295&#x2013;307. doi: 10.1007/s41030-023-00226-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41030-023-00226-y</ArticleId><ArticleId IdType="pmc">PMC10199290</ArticleId><ArticleId IdType="pubmed">37209374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.-M., Shin E.-C. Type I and III interferon responses in SARS-CoV-2 infection. Exp. Mol. Med. 2021;53:750&#x2013;760. doi: 10.1038/s12276-021-00592-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00592-0</ArticleId><ArticleId IdType="pmc">PMC8099704</ArticleId><ArticleId IdType="pubmed">33953323</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu D.-L., Martinez-Murillo P., Pigny F., Vono M., Meyer B., Eberhardt C.S., Lemeille S., Von Dach E., Blanchard-Rohner G., Eckerle I., et al. Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms. J. Clin. Immunol. 2021;41:1723&#x2013;1732. doi: 10.1007/s10875-021-01134-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01134-z</ArticleId><ArticleId IdType="pmc">PMC8476983</ArticleId><ArticleId IdType="pubmed">34581925</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidhu J.K., Siggins M.K., Liew F., Russell C.D., Uruchurtu A.S.S., Davis C., Turtle L., Moore S.C., E Hardwick H., Oosthuyzen W., et al. Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19. J. Infect. Dis. 2023;230:e17&#x2013;e29. doi: 10.1093/infdis/jiad590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad590</ArticleId><ArticleId IdType="pmc">PMC11272059</ArticleId><ArticleId IdType="pubmed">39052740</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolland-Debord C., Pi&#xe9;roni L., Bejar F., Milon A., Choinier P., Blin E., Bravais J., Halitim P., Letellier A., Camuset J., et al. Cell and cytokine analyses from bronchoalveolar lavage in non-critical COVID-19 pneumonia. Intern. Emerg. Med. 2023;18:1723&#x2013;1732. doi: 10.1007/s11739-023-03341-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-023-03341-5</ArticleId><ArticleId IdType="pubmed">37353659</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie C., Li Q., Li L., Peng X., Ling Z., Xiao B., Feng J., Chen Z., Chang D., Xie L., et al. Association of Early Inflammation with Age and Asymptomatic Disease in COVID-19. J. Inflamm. Res. 2021;14:1207&#x2013;1216. doi: 10.2147/JIR.S304190.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S304190</ArticleId><ArticleId IdType="pmc">PMC8020811</ArticleId><ArticleId IdType="pubmed">33833543</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid Y., Dor&#xe9; &#xc9;., Dubuc I., Archambault A.-S., Flamand O., Laviolette M., Flamand N., Boilard &#xc9;., Flamand L. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19. J. Allergy Clin. Immunol. 2021;148:368&#x2013;380.e3. doi: 10.1016/j.jaci.2021.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.05.032</ArticleId><ArticleId IdType="pmc">PMC8180473</ArticleId><ArticleId IdType="pubmed">34111453</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds D., Guillamet C.V., Day A., Borcherding N., Guillamet R.V., Chore&#xf1;o-Parra J.A., House S.L., O&#x2019;halloran J.A., Z&#xfa;&#xf1;iga J., Ellebedy A.H., et al. Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19. J. Immunol. 2021;207:1229&#x2013;1238. doi: 10.4049/jimmunol.2100294.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100294</ArticleId><ArticleId IdType="pmc">PMC8387368</ArticleId><ArticleId IdType="pubmed">34348975</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant R.A., Poor T.A., Sichizya L., Diaz E., Bailey J.I., Soni S., Senkow K.J., Perez-Leonor X.G., Abdala-Valencia H., Lu Z., et al. Prolonged exposure to lung-derived cytokines is associated with inflammatory activation of microglia in patients with COVID-19. bioRxiv. 2023 doi: 10.1101/2023.07.28.550765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.07.28.550765</ArticleId><ArticleId IdType="pmc">PMC11141878</ArticleId><ArticleId IdType="pubmed">38502186</ArticleId></ArticleIdList></Reference><Reference><Citation>Min C.-K., Cheon S., Ha N.-Y., Sohn K.M., Kim Y., Aigerim A., Shin H.M., Choi J.-Y., Inn K.-S., Kim J.-H., et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci. Rep. 2016;6:25359. doi: 10.1038/srep25359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25359</ArticleId><ArticleId IdType="pmc">PMC4857172</ArticleId><ArticleId IdType="pubmed">27146253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong C.K., Lam C.W.K., Wu A.K.L., Ip W.K., Lee N.L.S., Chan I.H.S., Lit L.C.W., Hui D.S.C., Chan M.H.M., Chung S.S.C., et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol. 2004;136:95&#x2013;103. doi: 10.1111/j.1365-2249.2004.02415.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2004.02415.x</ArticleId><ArticleId IdType="pmc">PMC1808997</ArticleId><ArticleId IdType="pubmed">15030519</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Zhang A., Wan Y., Liu X., Qiu C., Xi X., Ren Y., Wang J., Dong Y., Bao M., et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc. Natl. Acad. Sci. USA. 2014;111:769&#x2013;774. doi: 10.1073/pnas.1321748111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1321748111</ArticleId><ArticleId IdType="pmc">PMC3896201</ArticleId><ArticleId IdType="pubmed">24367104</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremoni M., Allouche J., Gra&#xe7;a D., Zorzi K., Fernandez C., Teisseyre M., Benzaken S., Ruetsch-Chelli C., Esnault V.L.M., Dellamonica J., et al. Low baseline IFN-&#x3b3; response could predict hospitalization in COVID-19 patients. Front. Immunol. 2022;13:953502. doi: 10.3389/fimmu.2022.953502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.953502</ArticleId><ArticleId IdType="pmc">PMC9548596</ArticleId><ArticleId IdType="pubmed">36225915</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X., Gebo K.A., Abraham A.G., Habtehyimer F., Patel E.U., Laeyendecker O., Gniadek T.J., Fernandez R.E., Baker O.R., Ram M., et al. Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: A prospective cohort study. Lancet Microbe. 2023;4:e692&#x2013;e703. doi: 10.1016/S2666-5247(23)00171-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00171-4</ArticleId><ArticleId IdType="pmc">PMC10475695</ArticleId><ArticleId IdType="pubmed">37659419</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins M.L., da Silva-Malta M.C.F., Ara&#xfa;jo A.L., Gon&#xe7;alves F.A., Botelho M.d.L., de Oliveira I.R., Boy L.d.S.M.F., Moreira H.M., Barbosa-Stancioli E.F., Ribeiro M.A., et al. A potent inflammatory response is triggered in asymptomatic blood donors with recent SARS-CoV-2 infection. Rev. Soc. Bras. Med. Trop. 2022;55:e0239&#x2013;2022. doi: 10.1590/0037-8682-0239-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0037-8682-0239-2022</ArticleId><ArticleId IdType="pmc">PMC9592101</ArticleId><ArticleId IdType="pubmed">36287506</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Q.-X., Tang X.-J., Shi Q.-L., Li Q., Deng H.-J., Yuan J., Hu J.-L., Xu W., Zhang Y., Lv F.-J., et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. 2020;26:1200&#x2013;1204. doi: 10.1038/s41591-020-0965-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0965-6</ArticleId><ArticleId IdType="pubmed">32555424</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjan L.H., Furukawa K., Nagano T., Kiriu T., Nishimura M., Arii J., Hino Y., Iwata S., Nishimura Y., Mori Y. Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019. J. Infect. Dis. 2021;223:1145&#x2013;1149. doi: 10.1093/infdis/jiab005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab005</ArticleId><ArticleId IdType="pmc">PMC7928883</ArticleId><ArticleId IdType="pubmed">33411935</ArticleId></ArticleIdList></Reference><Reference><Citation>Masood K.I., Yameen M., Ashraf J., Shahid S., Mahmood S.F., Nasir A., Nasir N., Jamil B., Ghanchi N.K., Khanum I., et al. Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome. Sci. Rep. 2021;11:22958. doi: 10.1038/s41598-021-02489-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-02489-4</ArticleId><ArticleId IdType="pmc">PMC8617268</ArticleId><ArticleId IdType="pubmed">34824360</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathy A.S., Vishwakarma S., Trimbake D., Gurav Y.K., Potdar V.A., Mokashi N.D., Patsute S.D., Kaushal H., Choudhary M.L., Tilekar B.N., et al. Pro-inflammatory CXCL-10, TNF-&#x3b1;, IL-1&#x3b2;, and IL-6: Biomarkers of SARS-CoV-2 infection. Arch. Virol. 2021;166:3301&#x2013;3310. doi: 10.1007/s00705-021-05247-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-05247-z</ArticleId><ArticleId IdType="pmc">PMC8459145</ArticleId><ArticleId IdType="pubmed">34554303</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith N., Goncalves P., Charbit B., Grzelak L., Beretta M., Planchais C., Bruel T., Rouilly V., Bondet V., Hadjadj J., et al. Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection. Nat. Immunol. 2021;22:1428&#x2013;1439. doi: 10.1038/s41590-021-01028-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01028-7</ArticleId><ArticleId IdType="pmc">PMC8553615</ArticleId><ArticleId IdType="pubmed">34471264</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H., Ma Q., Li C., Liu R., Zhao L., Wang W., Zhang P., Liu X., Gao G., Liu F., et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg. Microbes Infect. 2020;9:1123&#x2013;1130. doi: 10.1080/22221751.2020.1770129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1770129</ArticleId><ArticleId IdType="pmc">PMC7473317</ArticleId><ArticleId IdType="pubmed">32475230</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S.-W., Zhou Z., Wang J.-L., Deng Y.-F., Jing H., Qiu Y. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: A retrospective study. Virol. J. 2021;18:126. doi: 10.1186/s12985-021-01597-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01597-x</ArticleId><ArticleId IdType="pmc">PMC8197603</ArticleId><ArticleId IdType="pubmed">34118952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon J.-S., Kim J.Y., Kim M.-C., Park S.Y., Kim B.-N., Bae S., Cha H.H., Jung J., Lee M.J., Choi S.-H., et al. Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses. Am. J. Trop. Med. Hyg. 2020;103:2412&#x2013;2418. doi: 10.4269/ajtmh.20-1110.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-1110</ArticleId><ArticleId IdType="pmc">PMC7695090</ArticleId><ArticleId IdType="pubmed">33124544</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling L., Chen Z., Lui G., Wong C.K., Wong W.T., Ng R.W.Y., Tso E.Y.K., Fung K.S.C., Chan V., Yeung A.C.M., et al. Longitudinal Cytokine Profile in Patients with Mild to Critical COVID-19. Front. Immunol. 2021;12:763292. doi: 10.3389/fimmu.2021.763292.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.763292</ArticleId><ArticleId IdType="pmc">PMC8685399</ArticleId><ArticleId IdType="pubmed">34938289</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W., Li M., Luo G., Wu X., Su B., Zhao L., Zhang S., Chen X., Jia M., Zhu J., et al. The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression. J. Immunol. 2021;206:1597&#x2013;1608. doi: 10.4049/jimmunol.2001327.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2001327</ArticleId><ArticleId IdType="pubmed">33579725</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese F., Lunardi F., Baldasso E., Pezzuto F., Kilitci A., Olteanu G.-E., Del Vecchio C., Fortarezza F., Boscolo A., Schiavon M., et al. Comprehensive bronchoalveolar lavage characterization in COVID-19 associated acute respiratory distress syndrome patients: A prospective cohort study. Respir. Res. 2023;24:152. doi: 10.1186/s12931-023-02464-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-023-02464-9</ArticleId><ArticleId IdType="pmc">PMC10250841</ArticleId><ArticleId IdType="pubmed">37296478</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C., Wong P., Klein J., Castro T.B.R., Silva J., Sundaram M., Ellingson M.K., Mao T., Oh J.E., Israelow B., et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463&#x2013;469. doi: 10.1038/s41586-020-2588-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi Y., Ge Y., Wu B., Zhang W., Wu T., Wen T., Liu J., Guo X., Huang C., Jiao Y., et al. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China. J. Infect. Dis. 2020;222:746&#x2013;754. doi: 10.1093/infdis/jiaa363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa363</ArticleId><ArticleId IdType="pmc">PMC7337752</ArticleId><ArticleId IdType="pubmed">32563194</ArticleId></ArticleIdList></Reference><Reference><Citation>Bost P., De Sanctis F., Can&#xe8; S., Ugel S., Donadello K., Castellucci M., Eyal D., Fiore A., Anselmi C., Barouni R.M., et al. Deciphering the state of immune silence in fatal COVID-19 patients. Nat. Commun. 2021;12:1428. doi: 10.1038/s41467-021-21702-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21702-6</ArticleId><ArticleId IdType="pmc">PMC7935849</ArticleId><ArticleId IdType="pubmed">33674591</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandolfi L., Fossali T., Frangipane V., Bozzini S., Morosini M., D&#x2019;amato M., Lettieri S., Urtis M., Di Toro A., Saracino L., et al. Broncho-alveolar inflammation in COVID-19 patients: A correlation with clinical outcome. BMC Pulm. Med. 2020;20:301. doi: 10.1186/s12890-020-01343-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-020-01343-z</ArticleId><ArticleId IdType="pmc">PMC7668012</ArticleId><ArticleId IdType="pubmed">33198751</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Liu C., Liu J., Hu J., Yang Y., Zhou Y. Analysis of Risk Factors for 24 Patients With COVID-19 Developing from Moderate to Severe Condition. Front. Cell. Infect. Microbiol. 2020;10:548582. doi: 10.3389/fcimb.2020.548582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.548582</ArticleId><ArticleId IdType="pmc">PMC7523409</ArticleId><ArticleId IdType="pubmed">33042873</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Wang G., Long X., Hou H., Wei J., Cao Y., Tan J., Liu W., Meng F., Huang L., et al. Dynamics of Blood Viral Load Is Strongly Associated with Clinical Outcomes in Coronavirus Disease 2019 (COVID-19) Patients&#x2014;A Prospective Cohort Study. J. Mol. Diagn. 2021;23:10&#x2013;18. doi: 10.1016/j.jmoldx.2020.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmoldx.2020.10.007</ArticleId><ArticleId IdType="pmc">PMC7587132</ArticleId><ArticleId IdType="pubmed">33122141</ArticleId></ArticleIdList></Reference><Reference><Citation>MacCann R., Leon A.A.G., Gonzalez G., Carr M.J., Feeney E.R., Yousif O., Cotter A.G., de Barra E., Sadlier C., Doran P., et al. Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity. Front. Immunol. 2023;14:1166574. doi: 10.3389/fimmu.2023.1166574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1166574</ArticleId><ArticleId IdType="pmc">PMC10229044</ArticleId><ArticleId IdType="pubmed">37261339</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing A.G., Lorenc A., del Barrio I.D.M., Das A., Fish M., Monin L., Mu&#xf1;oz-Ruiz M., McKenzie D.R., Hayday T.S., Francos-Quijorna I., et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat. Med. 2020;26:1623&#x2013;1635. doi: 10.1038/s41591-020-1038-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1038-6</ArticleId><ArticleId IdType="pubmed">32807934</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos J.d.M.B.d., Soares C.P., Monteiro F.R., Mello R., Amaral J.B.D., Aguiar A.S., Soledade M.P., Sucupira C., De Paulis M., Andrade J.B., et al. In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection. Front. Immunol. 2021;12:595343. doi: 10.3389/fimmu.2021.595343.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.595343</ArticleId><ArticleId IdType="pmc">PMC7946815</ArticleId><ArticleId IdType="pubmed">33717074</ArticleId></ArticleIdList></Reference><Reference><Citation>Voiriot G., Dorgham K., Bachelot G., Fajac A., Morand-Joubert L., Parizot C., Gerotziafas G., Farabos D., Trugnan G., Eguether T., et al. Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients. Sci. Rep. 2022;12:9502. doi: 10.1038/s41598-022-13179-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13179-0</ArticleId><ArticleId IdType="pmc">PMC9178326</ArticleId><ArticleId IdType="pubmed">35681070</ArticleId></ArticleIdList></Reference><Reference><Citation>Joly C., Desjardins D., Porcher R., P&#xe9;r&#xe9; H., Bruneau T., Zhang Q., Bastard P., Cobat A., Resmini L., Lenoir O., et al. More rapid blood interferon &#x3b1;2 decline in fatal versus surviving COVID-19 patients. Front. Immunol. 2023;14:1250214. doi: 10.3389/fimmu.2023.1250214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1250214</ArticleId><ArticleId IdType="pmc">PMC10703045</ArticleId><ArticleId IdType="pubmed">38077399</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.-S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep. Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld M.S., Hsue P.Y., Peluso M.J., Deeks S.G. Findings from Mayo Clinic&#x2019;s Post-COVID Clinic: PASC Phenotypes Vary by Sex and Degree of IL-6 Elevation. Mayo Clin. Proc. 2022;97:430&#x2013;432. doi: 10.1016/j.mayocp.2022.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2022.01.020</ArticleId><ArticleId IdType="pmc">PMC8886352</ArticleId><ArticleId IdType="pubmed">35246280</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A., Vasaikar S.V., Lemos M.P., Moodie Z., Lee P.M.-P., Henderson K.E., Cohen K.W., Czartoski J.L., Lai L., Suthar M.S., et al. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. bioRxiv. 2021 doi: 10.1101/2021.05.26.442666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.26.442666</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Ruiz J., Lomel&#xed;n-Gasc&#xf3;n J., Luna J.L., Castro A.S.V., P&#xe9;rez-Fragoso A., Nu&#xf1;ez-Aguirre M., Alcal&#xe1;-Carmona B., Absal&#xf3;n-Aguilar A., Balderas-Miranda J.T., Maravillas-Montero J.L., et al. Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: A pilot study. Infect. Dis. 2023;55:243&#x2013;254. doi: 10.1080/23744235.2022.2158217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2022.2158217</ArticleId><ArticleId IdType="pubmed">36637466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik J.J., Bileck A., Hagn G., Meier-Menches S.M., Frey T., Kaempf A., Hollenstein M., Shoumariyeh T., Skos L., Reiter B., et al. A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. iScience. 2023;26:105717. doi: 10.1016/j.isci.2022.105717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105717</ArticleId><ArticleId IdType="pmc">PMC9719844</ArticleId><ArticleId IdType="pubmed">36507225</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Lu S., Tang A.F., Durstenfeld M.S., Ho H.-E., Goldberg S.A., Forman C.A., E Munter S., Hoh R., Tai V., et al. Markers of Immune Activation and Inflammation in Individuals with Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J. Infect. Dis. 2021;224:1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz M.A.F., das Neves P.F.M., Lima S.S., Lopes J.d.C., Torres M.K.d.S., Vallinoto I.M.V.C., de Brito M.T.F.M., da Silva A.L.S., Leite M.d.M., da Costa F.P., et al. Cytokine Profiles Associated with Acute COVID-19 and Long COVID-19 Syndrome. Front. Cell. Infect. Microbiol. 2022;12:922422. doi: 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontelli M.C., Castro &#xcd;.A., Martins R.B., La Serra L., Veras F.P., Nascimento D.C., Silva C.M., Cardoso R.S., Rosales R., Gomes R., et al. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients. J. Mol. Cell Biol. 2022;14 doi: 10.1093/jmcb/mjac021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjac021</ArticleId><ArticleId IdType="pmc">PMC9384834</ArticleId><ArticleId IdType="pubmed">35451490</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon J., Michelson D.A., Olejnik J., Chowdhary K., Oh H.S., Hume A.J., Galvan-Pena S., Zhu Y., Chen F., Vijaykumar B., et al. A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface. Proc. Natl. Acad. Sci. USA. 2022;119:e2116853118. doi: 10.1073/pnas.2116853118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2116853118</ArticleId><ArticleId IdType="pmc">PMC8740714</ArticleId><ArticleId IdType="pubmed">34969849</ArticleId></ArticleIdList></Reference><Reference><Citation>de Dios-Figueroa G.T., Aguilera-Marquez J.d.R., Camacho-Villegas T.A., Lugo-Fabres P.H. 3D Cell Culture Models in COVID-19 Times: A Review of 3D Technologies to Understand and Accelerate Therapeutic Drug Discovery. Biomedicines. 2021;9:602. doi: 10.3390/biomedicines9060602.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9060602</ArticleId><ArticleId IdType="pmc">PMC8226796</ArticleId><ArticleId IdType="pubmed">34073231</ArticleId></ArticleIdList></Reference><Reference><Citation>Clevers H. COVID-19: Organoids go viral. Nat. Rev. Mol. Cell Biol. 2020;21:355&#x2013;356. doi: 10.1038/s41580-020-0258-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-0258-4</ArticleId><ArticleId IdType="pmc">PMC7262486</ArticleId><ArticleId IdType="pubmed">32483314</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall L.J., Bailey J., Cassotta M., Herrmann K., Pistollato F. Poor Translatability of Biomedical Research Using Animals&#x2014;A Narrative Review. Altern. Lab. Anim. 2023;51:102&#x2013;135. doi: 10.1177/02611929231157756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/02611929231157756</ArticleId><ArticleId IdType="pubmed">36883244</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H., Chan J.F.-W., Yuen K.-Y. Animal models in SARS-CoV-2 research. Nat. Methods. 2022;19:392&#x2013;394. doi: 10.1038/s41592-022-01447-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-022-01447-w</ArticleId><ArticleId IdType="pubmed">35396468</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan C., Wu Y., Rui X., Yang Y., Ling C., Liu S., Liu S., Wang Y. Animal models for COVID-19: Advances, gaps and perspectives. Signal Transduct. Target. Ther. 2022;7:220. doi: 10.1038/s41392-022-01087-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01087-8</ArticleId><ArticleId IdType="pmc">PMC9261903</ArticleId><ArticleId IdType="pubmed">35798699</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen E.B., Orvold S.N., Swan C.L., Yourkowski A., Thivierge B.M., Francis M.E., Ge A., Rioux M., Darbellay J., Howland J.G., et al. After the virus has cleared&#x2014;Can preclinical models be employed for Long COVID research? PLoS Pathog. 2022;18 doi: 10.1371/journal.ppat.1010741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010741</ArticleId><ArticleId IdType="pmc">PMC9451097</ArticleId><ArticleId IdType="pubmed">36070309</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenke K., Okumura A., Lewis M.C., Feldmann F., Meade-White K., Bohler W.F., Griffin A.J., Rosenke R., Shaia C., Jarvis M.A., et al. Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model. J. Clin. Investig. 2022;7:e160108. doi: 10.1172/jci.insight.160108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.160108</ArticleId><ArticleId IdType="pmc">PMC9310535</ArticleId><ArticleId IdType="pubmed">35579953</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelnabi R., Foo C.S., Jochmans D., Vangeel L., De Jonghe S., Augustijns P., Mols R., Weynand B., Wattanakul T., Hoglund R.M., et al. The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern. Nat. Commun. 2022;13:719. doi: 10.1038/s41467-022-28354-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28354-0</ArticleId><ArticleId IdType="pmc">PMC8847371</ArticleId><ArticleId IdType="pubmed">35169114</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong J.H., Chokkakula S., Min S.C., Kim B.K., Choi W.-S., Oh S., Yun Y.S., Kang D.H., Lee O.-J., Kim E.-G., et al. Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice. Antivir. Res. 2022;208:105430. doi: 10.1016/j.antiviral.2022.105430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2022.105430</ArticleId><ArticleId IdType="pmc">PMC9535923</ArticleId><ArticleId IdType="pubmed">36209984</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., Serafini R.A., Pryce K.D., Zazhytska M., Oishi K., Golynker I., Panis M., Zimering J., Horiuchi S., Hoagland D.A., et al. SARS-CoV-2 Infection in Hamsters and Humans Results in Lasting and Unique Systemic Perturbations after Recovery. Sci. Translational Med. 2022;14:eabq3059. doi: 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Yinda C.K., Port J.R., Bushmaker T., Offei Owusu I., Purushotham J.N., Avanzato V.A., Fischer R.J., Schulz J.E., Holbrook M.G., Hebner M.J., et al. K18-hACE2 mice develop respiratory disease resembling severe COVID-19. PLoS Pathog. 2021;17:e1009195. doi: 10.1371/journal.ppat.1009195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009195</ArticleId><ArticleId IdType="pmc">PMC7875348</ArticleId><ArticleId IdType="pubmed">33465158</ArticleId></ArticleIdList></Reference><Reference><Citation>Gressett T.E., Leist S.R., Ismael S., Talkington G., Dinnon K.H., Baric R.S., Bix G. Mouse Adapted SARS-CoV-2 Model Induces &#x201c;Long-COVID&#x201d; Neuropathology in BALB/c Mice. bioRxiv. 2023 doi: 10.1101/2023.03.18.533204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.03.18.533204</ArticleId></ArticleIdList></Reference><Reference><Citation>Handley A., Ryan K.A., Davies E.R., Bewley K.R., Carnell O.T., Challis A., Coombes N.S., Fotheringham S.A., Gooch K.E., Charlton M., et al. SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum. Viruses. 2023;15:748. doi: 10.3390/v15030748.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15030748</ArticleId><ArticleId IdType="pmc">PMC10051760</ArticleId><ArticleId IdType="pubmed">36992457</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyna R.A., Kishimoto-Urata M., Urata S., Makishima T., Paessler S., Maruyama J. Recovery of anosmia in hamsters infected with SARS-CoV-2 is correlated with repair of the olfactory epithelium. Sci. Rep. 2022;12:628. doi: 10.1038/s41598-021-04622-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-04622-9</ArticleId><ArticleId IdType="pmc">PMC8755745</ArticleId><ArticleId IdType="pubmed">35022504</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterrieder N., Bertzbach L.D., Dietert K., Abdelgawad A., Vladimirova D., Kunec D., Hoffmann D., Beer M., Gruber A.D., Trimpert J. Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters. Viruses. 2020;12:779. doi: 10.3390/v12070779.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12070779</ArticleId><ArticleId IdType="pmc">PMC7412213</ArticleId><ArticleId IdType="pubmed">32698441</ArticleId></ArticleIdList></Reference><Reference><Citation>Briand F., Sencio V., Robil C., Heumel S., Deruyter L., Machelart A., Barthelemy J., Bogard G., Hoffmann E., Infanti F., et al. Diet-Induced Obesity and NASH Impair Disease Recovery in SARS-CoV-2-Infected Golden Hamsters. Viruses. 2022;14:2067. doi: 10.3390/v14092067.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14092067</ArticleId><ArticleId IdType="pmc">PMC9503118</ArticleId><ArticleId IdType="pubmed">36146875</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Ven K., van Dijken H., Wijsman L., Gomersbach A., Schouten T., Kool J., Lenz S., Roholl P., Meijer A., van Kasteren P.B., et al. Pathology and Immunity After SARS-CoV-2 Infection in Male Ferrets Is Affected by Age and Inoculation Route. Front. Immunol. 2021;12:750229. doi: 10.3389/fimmu.2021.750229.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.750229</ArticleId><ArticleId IdType="pmc">PMC8566349</ArticleId><ArticleId IdType="pubmed">34745122</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>